Safety and Temporal Pattern of the Lymphocyte Count During Fingolimod Therapy in Patients With Multiple Sclerosis: Real-World Korean Experience

BACKGROUND AND PURPOSE: Fingolimod (FTY) inhibits lymphocyte egress from lymphoid organs to cause lymphopenia, but the clinical implications of FTY-induced lymphopenia are not fully understood. We aimed to determine the frequency and severity of lymphopenia during FTY treatment among Korean patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Huh, So-Young, Kim, Su-Hyun, Kim, Ki Hoon, Kwon, Young Nam, Kim, Sung-Min, Kim, Seung Woo, Shin, Ha Young, Chung, Yeon Hak, Min, Ju-Hong, So, Jungmin, Lim, Young-Min, Kim, Kwang-Kuk, Kim, Nam-Hee, Nam, Tai-Seung, Kang, Sa-Yoon, Oh, Jeeyoung, Oh, Seong-il, Sohn, Eunhee, Kim, Ho Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurological Association 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669559/
https://www.ncbi.nlm.nih.gov/pubmed/36367064
http://dx.doi.org/10.3988/jcn.2022.18.6.663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669559/
https://www.ncbi.nlm.nih.gov/pubmed/36367064
http://dx.doi.org/10.3988/jcn.2022.18.6.663

Ejemplares similares